Charles W. Ford

4.2k total citations · 1 hit paper
41 papers, 3.3k citations indexed

About

Charles W. Ford is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Charles W. Ford has authored 41 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Organic Chemistry and 12 papers in Infectious Diseases. Recurrent topics in Charles W. Ford's work include Synthesis and biological activity (9 papers), Phenothiazines and Benzothiazines Synthesis and Activities (9 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Charles W. Ford is often cited by papers focused on Synthesis and biological activity (9 papers), Phenothiazines and Benzothiazines Synthesis and Activities (9 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Charles W. Ford collaborates with scholars based in United States, Canada and United Kingdom. Charles W. Ford's co-authors include Michael R. Barbachyn, Gary E. Zurenko, Douglas K. Hutchinson, Kevin C. Grega, Judith C. Hamel, Steven J. Brickner, David W. Holden, Douglas Stapert, Stuart A. Garmon and Robert J. Yancey and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Charles W. Ford

41 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Substituent Effects on the Antibacterial Activity of Nitrogen−Carbon-Linked (Azolylphenyl)oxazolidinones with Expanded Activity Against the Fastidious Gram-Negative Organisms Haemophilus influenzae and Moraxella catarrhalis

2000 662 citations Michaël Génin, Michael R. Barbachyn et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles W. Ford United States	24	1.6k	1.2k	855	343	326	41	3.3k
Michael R. Barbachyn United States	23	2.1k 1.4×	1.4k 1.1×	1.1k 1.3×	499 1.5×	371 1.1×	38	3.7k
Norton P. Peet United States	37	2.1k 1.3×	1.5k 1.3×	354 0.4×	261 0.8×	408 1.3×	190	4.2k
Youhei Takeda Japan	51	1.9k 1.2×	819 0.7×	485 0.6×	51 0.1×	63 0.2×	185	8.0k
Jacob J. Plattner United States	34	2.3k 1.5×	2.1k 1.8×	989 1.2×	295 0.9×	699 2.1×	113	4.8k
Kevin Kavanagh Ireland	57	1.8k 1.2×	2.3k 2.0×	2.0k 2.4×	788 2.3×	1.2k 3.8×	243	9.5k
Dušan Hesek United States	41	1.2k 0.8×	1.7k 1.5×	558 0.7×	297 0.9×	322 1.0×	138	4.6k
Jun Zheng China	29	307 0.2×	1.1k 0.9×	701 0.8×	174 0.5×	232 0.7×	82	3.5k
Thomas A. Keating United States	30	1.9k 1.2×	2.2k 1.9×	206 0.2×	1.2k 3.4×	157 0.5×	57	4.1k
John J. Nash United States	30	996 0.6×	843 0.7×	270 0.3×	45 0.1×	131 0.4×	139	3.6k
R. F. Pratt United States	36	995 0.6×	1.5k 1.2×	456 0.5×	845 2.5×	726 2.2×	157	3.8k

Countries citing papers authored by Charles W. Ford

Since Specialization

Citations

This map shows the geographic impact of Charles W. Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles W. Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles W. Ford more than expected).

Fields of papers citing papers by Charles W. Ford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles W. Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles W. Ford. The network helps show where Charles W. Ford may publish in the future.

Co-authorship network of co-authors of Charles W. Ford

This figure shows the co-authorship network connecting the top 25 collaborators of Charles W. Ford. A scholar is included among the top collaborators of Charles W. Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles W. Ford. Charles W. Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barbachyn, Michael R. & Charles W. Ford. (2003). Oxazolidinone Structure–Activity Relationships Leading to Linezolid. Angewandte Chemie International Edition. 42(18). 2010–2023. 457 indexed citations

Ciske, Fred L., Michael R. Barbachyn, Michaël Génin, et al.. (2003). The effect of remote chirality on the antibacterial activity of indolinyl, tetrahydroquinolyl and dihydrobenzoxazinyl oxazolidinones. Bioorganic & Medicinal Chemistry Letters. 13(23). 4235–4239. 22 indexed citations

Thomasco, Lisa M., Robert C. Gadwood, Elizabeth A. Weaver, et al.. (2003). The synthesis and antibacterial activity of 1,3,4-Thiadiazole phenyl oxazolidinone analogues. Bioorganic & Medicinal Chemistry Letters. 13(23). 4193–4196. 54 indexed citations

Johnson, Paul D., Paul A. Aristoff, Gary E. Zurenko, et al.. (2003). Synthesis and biological evaluation of benzazepine oxazolidinone antibacterials. Bioorganic & Medicinal Chemistry Letters. 13(23). 4197–4200. 30 indexed citations

Ford, Charles W.. (2002). The Psychologist's Book of Personality Tests. 31(1). 51. 13 indexed citations

Brickner, Steven J., Peter R. Manninen, Douglas C. Rohrer, et al.. (1998). Synthesis and antibacterial activity of [6,5,5] and [6,6,5] tricyclic fused oxazolidinones. Bioorganic & Medicinal Chemistry Letters. 8(10). 1231–1236. 26 indexed citations

Barbachyn, Michael R., Steven J. Brickner, Robert C. Gadwood, et al.. (1998). Design, Synthesis, and Evaluation of Novel Oxazolidinone Antibacterial Agents Active Against Multidrug-Resistant Bacteria. Advances in experimental medicine and biology. 456. 219–238. 15 indexed citations

Zurenko, Gary E., et al.. (1997). Oxazolidinone antibacterial agents: development of the clinical candidates eperezolid and linezolid. Expert Opinion on Investigational Drugs. 6(2). 151–158. 33 indexed citations

Ford, Charles W., Judith C. Hamel, Douglas Stapert, et al.. (1997). Oxazolidinones: New antibacterial agents. Trends in Microbiology. 5(5). 196–200. 56 indexed citations

10.

Ford, Charles W., et al.. (1997). Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature‐tagged mutagenesis. Molecular Microbiology. 26(2). 399–407. 357 indexed citations

11.

Ford, Charles W., et al.. (1994). Efficacy of Tumor Necrosis Factor-α and Antibiotics in Therapy of Experimental Murine Staphylococcal Mastitis. Journal of Dairy Science. 77(5). 1259–1266. 10 indexed citations

12.

Ford, Charles W., et al.. (1994). Effect of Tumor Necrosis Factor-α, Interleukin-1β, and Antibiotics on the Killing of Intracellular Staphylococcus aureus. Journal of Dairy Science. 77(5). 1251–1258. 21 indexed citations

13.

Yancey, Robert J., et al.. (1991). Activity of antibiotics againstStaphylococcus aureus within polymorphonuclear neutrophils. European Journal of Clinical Microbiology & Infectious Diseases. 10(2). 107–113. 46 indexed citations

14.

Ford, Charles W., Judith C. Hamel, Douglas Stapert, & Robert J. Yancey. (1989). Establishment of an experimental model of a Staphylococcus aureus abscess in mice by use of dextran and gelatin microcarriers. Journal of Medical Microbiology. 28(4). 259–266. 56 indexed citations

15.

Zurenko, Gary E., et al.. (1988). Trospectomycin, a novel spectinomycin analogue: antibacterial activity and preliminary human pharmacokinetics.. PubMed. 14(6). 403–9. 8 indexed citations

16.

Ford, Charles W., et al.. (1988). Evaluation of antibiotic effectiveness against Staphylococcus aureus surviving within the bovine mammary gland macrophage. Journal of Antimicrobial Chemotherapy. 21(6). 773–786. 29 indexed citations

17.

Yancey, Robert J., et al.. (1987). Ceftiofur sodium, a broad-spectrum cephalosporin: Evaluation in vitro and in vivo in mice. American Journal of Veterinary Research. 48(7). 1050–1053. 41 indexed citations

18.

Ford, Charles W., et al.. (1986). Evaluation of antibacterial agents in a high-volume bovine polymorphonuclear neutrophil Staphylococcus aureus intracellular killing assay. Antimicrobial Agents and Chemotherapy. 29(4). 634–638. 23 indexed citations

19.

Ford, Charles W.. (1978). Clinical education for the allied health professions. Mosby eBooks. 22 indexed citations

20.

Ford, Charles W., et al.. (1976). Teaching in the health professions. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact